Octyl-2-cyanoacrylate Tissue Adhesive Closure Versus Subcuticular Suture for Post-Auricular Incisions. 2024

Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
Department of Otology, Neurotology and Cochlear Implant Surgery, Ohud Hospital, Al Madinah Almunawarah, Saudi Arabia.

BACKGROUND Skin closure techniques in otolaryngology vary based on surgeon preference and wound site. Octyl-2-Cyanoacrylate may be a safe, rapid, and cost-effective option for post-site closure. OBJECTIVE This randomized controlled trial study aimed to compare Octyl-2-Cyanoacrylate and conventional subcuticular sutures in ear surgeries, assessing wound closure results in both case and control groups. METHODS This prospective, randomized, controlled, single-blind study was conducted at Ohud Hospital from May 2021 to May 2022. Ear surgery and cochlear implantation in patients were examined, and each group was randomly assigned to receive Dermabond TM and deep layer subcuticular sutures closure. Incisions were assessed at various time points, including 3 weeks, 6 weeks, 6 months, and 1 year post-surgery. The patient and observer Scar Assessment Scale was used, and two independent ear surgeons used the Stony Brook Scar Evaluation Scale for initial scar assessment. RESULTS This study involved 126 ear surgery and cochlear implantation patients randomized to use cyanoacrylate tissue adhesive or subcuticular suture for port site closure. The study found that tissue adhesive (OCA) was faster and more efficient than standard sutures, saving an average of 12 min per incision in each ear. Incision cosmesis showed immediate results and significant differences, and patient satisfaction with OCA wound closure was higher than standard sutures. CONCLUSIONS The findings confirmed that cyanoacrylate tissue adhesive significantly reduced the time needed for skin closure during ear surgery and showed immediate cosmetic improvements without any documented instances of bleeding, hematoma, infection, or wound separation. METHODS This is a randomized controlled trial, it follows Level 2 of evidence. Randomized trial or observational study with dramatic effects Laryngoscope, 2024.

UI MeSH Term Description Entries

Related Publications

Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
January 2015, Annals of plastic surgery,
Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
January 2017, Journal of vascular and interventional radiology : JVIR,
Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
January 2018, PloS one,
Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
July 2011, Journal of cardiac surgery,
Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
October 2018, Plastic and reconstructive surgery,
Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
January 2015, In vivo (Athens, Greece),
Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
January 2003, Journal of pediatric ophthalmology and strabismus,
Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
February 2009, Annals of emergency medicine,
Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
May 2005, Ophthalmic plastic and reconstructive surgery,
Mariam Jaber Aljehani, and Marzouqi Salamah, and Roa Halwani, and Mansour Alshamani
November 1995, Annals of emergency medicine,
Copied contents to your clipboard!